Tumor Microenvironment.
cancer
cancer-microenvironment
tumor
tumor-growth
tumor-microenvironment
Journal
Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208
Informations de publication
Date de publication:
30 Dec 2019
30 Dec 2019
Historique:
received:
22
11
2019
revised:
21
12
2019
accepted:
27
12
2019
entrez:
8
1
2020
pubmed:
8
1
2020
medline:
17
6
2020
Statut:
epublish
Résumé
The tumor microenvironment has been widely implicated in tumorigenesis because it harbors tumor cells that interact with surrounding cells through the circulatory and lymphatic systems to influence the development and progression of cancer. In addition, nonmalignant cells in the tumor microenvironment play critical roles in all the stages of carcinogenesis by stimulating and facilitating uncontrolled cell proliferation. This study aims to explore the concept of the tumor microenvironment by conducting a critical review of previous studies on the topic. The tumor microenvironment has received significant attention in the cancer literature, with a particular focus on its role in tumor development and progression. Previous studies have identified various components of the tumor microenvironment that influence malignant behavior and progression. In addition to malignant cells, adipocytes, fibroblasts, tumor vasculature, lymphocytes, dendritic cells, and cancer-associated fibroblasts are present in the tumor microenvironment. Each of these cell types has unique immunological capabilities that determine whether the tumor will survive and affect neighboring cells. The tumor microenvironment harbors cancer stem cells and other molecules that contribute to tumor development and progression. Consequently, targeting and manipulating the cells and factors in the tumor microenvironment during cancer treatment can help control malignancies and achieve positive health outcomes.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
The tumor microenvironment has been widely implicated in tumorigenesis because it harbors tumor cells that interact with surrounding cells through the circulatory and lymphatic systems to influence the development and progression of cancer. In addition, nonmalignant cells in the tumor microenvironment play critical roles in all the stages of carcinogenesis by stimulating and facilitating uncontrolled cell proliferation.
AIM
OBJECTIVE
This study aims to explore the concept of the tumor microenvironment by conducting a critical review of previous studies on the topic.
RESULTS AND DISCUSSION
CONCLUSIONS
The tumor microenvironment has received significant attention in the cancer literature, with a particular focus on its role in tumor development and progression. Previous studies have identified various components of the tumor microenvironment that influence malignant behavior and progression. In addition to malignant cells, adipocytes, fibroblasts, tumor vasculature, lymphocytes, dendritic cells, and cancer-associated fibroblasts are present in the tumor microenvironment. Each of these cell types has unique immunological capabilities that determine whether the tumor will survive and affect neighboring cells.
CONCLUSION
CONCLUSIONS
The tumor microenvironment harbors cancer stem cells and other molecules that contribute to tumor development and progression. Consequently, targeting and manipulating the cells and factors in the tumor microenvironment during cancer treatment can help control malignancies and achieve positive health outcomes.
Identifiants
pubmed: 31906017
pii: medicina56010015
doi: 10.3390/medicina56010015
pmc: PMC7023392
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The author declares no conflict of interest.
Références
Cold Spring Harb Perspect Med. 2012 Dec 01;2(12):a006676
pubmed: 23209177
Cancers (Basel). 2015 Dec 11;7(4):2443-58
pubmed: 26690480
Future Oncol. 2019 Jul;15(20):2337-2348
pubmed: 31184937
Curr Opin Pharmacol. 2017 Aug;35:40-47
pubmed: 28577499
Int J Mol Sci. 2019 Dec 25;21(1):
pubmed: 31881671
Science. 2010 Nov 5;330(6005):827-30
pubmed: 21051638
Stem Cell Res Ther. 2013 Nov 15;4(6):138
pubmed: 24456712
Breast Cancer Res Treat. 2009 Sep;117(1):223-4
pubmed: 18979196
Crit Rev Immunol. 2012;32(2):139-55
pubmed: 23216612
Science. 2014 May 23;344(6186):921-5
pubmed: 24812208
Adv Immunol. 2014;122:91-128
pubmed: 24507156
Annu Rev Immunol. 2012;30:221-41
pubmed: 22224776
Nat Rev Cancer. 2019 Feb;19(2):65-81
pubmed: 30647431
Nat Rev Immunol. 2012 Feb 10;12(3):157-67
pubmed: 22322317
Biomed Rep. 2013 Jul;1(4):517-521
pubmed: 24648978
Cancer Lett. 2017 May 1;393:60-67
pubmed: 28216373
Curr Opin Biotechnol. 2016 Aug;40:41-48
pubmed: 26938687
J Immunol Res. 2015;2015:652875
pubmed: 26543874
Lancet Oncol. 2011 Apr;12(4):387-98
pubmed: 21463833
Cytokine. 2017 Jan;89:127-135
pubmed: 26854213
Am J Physiol Cell Physiol. 2014 Jul 1;307(1):C25-38
pubmed: 24788248
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Int J Mol Sci. 2018 Oct 04;19(10):
pubmed: 30287763
Cell Mol Gastroenterol Hepatol. 2016 Sep 14;2(6):733-749
pubmed: 28105461
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20212-7
pubmed: 24277834
Front Biosci (Landmark Ed). 2010 Jan 01;15:166-79
pubmed: 20036813
Nat Rev Cancer. 2017 Oct;17(10):577-593
pubmed: 28912578
Nat Med. 2011 Oct 30;17(11):1498-503
pubmed: 22037646
Nat Immunol. 2016 Aug 19;17(9):1025-36
pubmed: 27540992
Curr Opin Immunol. 2013 Apr;25(2):261-7
pubmed: 23579076
Appl Immunohistochem Mol Morphol. 2010 May;18(3):206-11
pubmed: 20065852
Nat Rev Immunol. 2012 Mar 22;12(4):239-52
pubmed: 22437937
Cancer Cell. 2012 Jun 12;21(6):822-35
pubmed: 22698406
Cancer Cell. 2012 Mar 20;21(3):309-22
pubmed: 22439926
Immunol Rev. 2006 Jun;211:214-24
pubmed: 16824130
Stem Cells. 2017 May;35(5):1123-1130
pubmed: 28207184
Cancer Immunol Res. 2014 Mar;2(3):200-6
pubmed: 24778316
BMC Med. 2015 Mar 05;13:45
pubmed: 25857315
Stem Cell Res Ther. 2016 Sep 09;7(1):131
pubmed: 27612948
J Tissue Viability. 2011 Nov;20(4):108-20
pubmed: 19995679
Lab Invest. 2012 Jan;92(1):151-62
pubmed: 21894147
Cancer Cell. 2010 Feb 17;17(2):121-34
pubmed: 20138013
Sci Rep. 2015 Nov 20;5:16941
pubmed: 26585689
J Exp Med. 2012 Jun 4;209(6):1153-65
pubmed: 22615130
Cell Rep. 2015 Apr 7;11(1):85-97
pubmed: 25818301
FASEB J. 2014 Jul;28(7):2762-74
pubmed: 24652949
Cancer Discov. 2011 Jun;1(1):54-67
pubmed: 22039576
Nat Rev Immunol. 2011 Sep 23;11(10):702-11
pubmed: 21941296
Blood. 2013 Apr 25;121(17):3386-95
pubmed: 23430111
Adv Exp Med Biol. 2014;812:19-24
pubmed: 24729210
PLoS One. 2011 Mar 31;6(3):e18219
pubmed: 21483813
Hum Pathol. 2010 Dec;41(12):1794-801
pubmed: 21078439
Nat Rev Cancer. 2019 Jul;19(7):371-376
pubmed: 31186547
Tissue Cell. 2017 Dec;49(6):711-718
pubmed: 29054337
Nat Rev Drug Discov. 2014 Jul;13(7):497-512
pubmed: 24981363
Cancer Res. 2011 May 15;71(10):3505-15
pubmed: 21444674
Blood. 2012 Mar 29;119(13):3073-83
pubmed: 22251483
Nature. 2008 Jul 24;454(7203):436-44
pubmed: 18650914
Mol Ther. 2012 Jan;20(1):14-20
pubmed: 22008910
Stem Cells Transl Med. 2017 Dec;6(12):2115-2125
pubmed: 29072369
Cancer Cell. 2012 Jun 12;21(6):836-47
pubmed: 22698407
Nat Med. 2002 Aug;8(8):793-800
pubmed: 12091876
Adv Hematol. 2011;2011:501659
pubmed: 20975771
Cancer J. 2015 May-Jun;21(3):174-8
pubmed: 26049696
J Mammary Gland Biol Neoplasia. 2011 Sep;16(3):205-19
pubmed: 21822945
PLoS One. 2009;4(4):e4992
pubmed: 19352430
Cell Stem Cell. 2015 Mar 5;16(3):225-38
pubmed: 25748930
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Cancer Res. 2012 May 15;72(10):2473-80
pubmed: 22414581
Cell Death Dis. 2017 Jan 19;8(1):e2568
pubmed: 28102844
Nat Med. 2011 Aug 04;17(8):929-30
pubmed: 21818088
Expert Rev Anticancer Ther. 2015;15(8):943-54
pubmed: 26098949
Oncotarget. 2015 Oct 13;6(31):30472-86
pubmed: 26421710
Cell. 2010 Mar 19;140(6):883-99
pubmed: 20303878
Cancer Res. 2016 Feb 1;76(3):513-6
pubmed: 26772756
Cancer Metastasis Rev. 2013 Jun;32(1-2):303-15
pubmed: 23114846
Nat Immunol. 2013 Oct;14(10):1014-22
pubmed: 24048123
Immunol Cell Biol. 2010 Feb;88(2):165-71
pubmed: 19841638
J Cell Sci. 2012 Dec 1;125(Pt 23):5591-6
pubmed: 23420197
Nat Med. 2004 Jan;10(1):48-54
pubmed: 14702634
Hepatology. 2019 Dec 25;:
pubmed: 31875970
Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10662-7
pubmed: 21670304
Breast Cancer Res. 2016 Aug 11;18(1):84
pubmed: 27515302
Nat Rev Immunol. 2012 Mar 22;12(4):253-68
pubmed: 22437938